Revere, MA, United States of America

Ye Sun

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Abbvie Deutschland Gmbh and Co Kg, Abbvie Inc., Wisconsin Alumni Research Foundation. Active years: 2015.


% Patents Active = 100.0



Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ye Sun - Innovator in Pharmaceutical Formulations

Introduction

Ye Sun is a notable inventor based in Revere, MA (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in enhancing the bioavailability of poorly soluble drugs. Her innovative approach addresses the challenges associated with the solubility of crystalline substances in polymer matrices.

Latest Patents

Ye Sun holds a patent for a method titled "Method for evaluating the solubility of a crystalline substance in a polymer." This invention presents a viable strategy to enhance the bioavailability of poorly soluble drugs by using amorphous solids instead of crystalline solids in pharmaceutical formulations. The method utilizes Differential Scanning Calorimetry (DSC) to measure the solubility of crystalline drugs in polymeric matrices, overcoming the challenges posed by the high viscosity of polymers and the structural relaxation of drug/polymer dispersions over time. She has 1 patent to her name.

Career Highlights

Throughout her career, Ye Sun has worked with prominent companies in the pharmaceutical industry, including AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. Her work has focused on developing innovative solutions to improve drug formulations and delivery systems.

Collaborations

Ye Sun has collaborated with notable professionals in her field, including Markus Maegerlein and Geoff G. Zhang. These collaborations have contributed to her research and development efforts in pharmaceutical sciences.

Conclusion

Ye Sun's innovative methods and dedication to improving drug solubility have made her a valuable contributor to the pharmaceutical industry. Her work continues to influence the development of effective drug formulations that enhance patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…